Skip to main content
INBIOGEN CO.,Ltd logo

INBIOGEN CO.,Ltd — Investor Relations & Filings

Ticker · 101140 ISIN · KR7101140002 KO Professional, scientific and technical activities
Open in API
Filings indexed 342 across all filing types
Latest filing 2022-06-27 Board/Management Inform…
Country KR South Korea
Listing KO 101140

About INBIOGEN CO.,Ltd

https://www.inbiogen.com/

INBIOGEN is a life sciences company that provides Virtual Biotech Assistance to international biotechnology companies, pharmaceutical firms, and research organizations. The company specializes in harnessing data mining to deliver a range of services, including bioinformatics, custom data curation, database development, and the creation of operational platforms. Core bioinformatics offerings encompass data analysis, protein modeling, homology searches, phylogeny, and immunogenicity analysis. Additionally, INBIOGEN provides virtual research, marketing assistance, and web development services. The company focuses on creating customized, value-added solutions through a team of experienced scientists and bioinformatics professionals to help clients address challenges and utilize online resources effectively.

Recent filings

Filing Released Lang Actions
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 100% confidence The document is a regulatory filing submitted to the Financial Services Commission/Korea Exchange regarding the resignation of an outside director (사외이사). This falls under the category of changes in board or management personnel.
2022-06-27 Korean
[기재정정]주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) regarding the 'Decision to Issue Convertible Bonds' (전환사채권 발행결정) and specifically acts as a 'Correction Report' (정정신고) for a previously filed issuance. It details changes to bond maturity, conversion prices, and issuance dates. In the context of Korean regulatory filings (DART), this type of document is a formal disclosure of capital structure changes and financing activities, which falls under the 'Capital/Financing Update' category.
2022-06-27 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership by a major shareholder (Bucket Studio) in the issuer (Inbiogen) due to the adjustment of conversion prices for convertible preferred shares. This falls under the category of 'Major Shareholding Notification' (MRQ).
2022-06-03 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Financial Supervisory Service in South Korea. This type of filing is a mandatory disclosure by insiders (directors, executives, or major shareholders) regarding their holdings and changes in ownership of company securities. In the provided taxonomy, this corresponds to 'Director's Dealing' (DIRS), which covers insider transactions and ownership status reports.
2022-06-03 Korean
[기재정정]주요사항보고서(전환사채권발행결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) from a South Korean company, Inbiogen, specifically detailing an amendment (정정신고) to a previously filed Convertible Bond issuance. It outlines changes to maturity dates, conversion periods, and call/put option terms. This type of regulatory filing regarding capital structure and financing instruments falls under the 'Capital/Financing Update' category.
2022-05-31 Korean
[기재정정]주요사항보고서(전환사채권발행결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matters Report' (주요사항보고서) from a South Korean company, Inbiogen, specifically detailing a correction (정정신고) to a previously filed Convertible Bond issuance (전환사채권 발행결정). It outlines changes to the conversion price, the target investor, and the issuance schedule. In the context of Korean regulatory filings (DART), this is a formal disclosure of a capital-raising event and its subsequent amendments. Since it details the terms of financing and capital structure changes, it falls under the 'Capital/Financing Update' category.
2022-05-23 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.